Navigation Links
Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
Date:2/19/2009

erance, retention and other related plant closure costs. These charges and other items are excluded from Watson's 2009 adjusted EBITDA and earnings per diluted share forecasts as detailed in Table 6 and 7 below.

For 2009, the Company expects adjusted diluted earnings per share to be between $2.18 and $2.28 and GAAP earnings per diluted share between $2.03 and $2.13. Adjusted EBITDA is expected to be between $600 million and $620 million.

This forecast includes only a modest contribution from Watson's sales of generic Micro-K(R) and generic Toprol XL(R). Due to production issues experienced by certain competitors, there is currently a supply disruption for these products. If the current competitive landscape for these two products does not change significantly and we are able to obtain timely approval for our generic Toprol XL(R) product, it is likely that the Company will significantly exceed its current earnings per share forecast.

Webcast and Conference Call Details

Watson will host a conference call and webcast today at 8:30 a.m. Eastern Standard Time to discuss fourth quarter 2008 results, the outlook for 2009 and recent corporate developments. The dial-in number to access the call is (877) 251-7980, or from international locations, (706) 643-1573. A taped replay of the call will be available by calling (800) 642-1687 with access pass code 82174623. The replay may be accessed from international locations by dialing (706) 645-9291 and using the same pass code. This replay will remain in effect until midnight Eastern Standard Time, February 27, 2009. To access the live webcast, go to Watson Investor Relations Web site at http://ir.watson.com.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
2. Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation
3. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
4. Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
5. U.S. Workers Taking Steps to Lower Medical Costs, Watson Wyatt Survey Finds
6. China Shenghuo Announces Additional Roll-Out of 12 Ways Cosmetics Products to Watsons Stores
7. Driving Consumer Engagement Is Focus of Address by Healthfitness Chief Medical Officer at Watson Wyatt Health Care Solutions Event
8. Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg
9. Watson Enters Into Agreement to Acquire Products Related to Tevas Proposed Acquisition of Barr
10. Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
11. Watson Pharmaceuticals Reports Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... may be able to convince your brain that healthy foods ... study included eight overweight and obese people who were enrolled ... people react to different foods. These participants were compared to ... weren,t in the program. Both groups had MRI brain ... months later. The scans revealed that the people in the ...
(Date:9/1/2014)... NY (PRWEB) September 01, 2014 More ... been added to a federal litigation that continues to ... Carolina, Bernstein Liebhard LLP reports. , A federal ... now filed over the widely-used cholesterol medication by plaintiffs ... drug. According to claims, Pfizer Inc. failed to adequately ...
(Date:9/1/2014)... Barcelona, Spain Monday 1 September 2014: Permanent atrial ... paroxysmal AF, according to research in more than 6 ... Thomas Vanassche from Belgium. The findings suggest that a ... help doctors to better estimate stroke risk. , Ischaemic ... EU, accounting for over a million deaths and many ...
(Date:9/1/2014)... September 01, 2014 In honor of National Take ... 22, Animal Emergency & Referral Center of Minnesota (AERC) is offering ... priority for their cats. , Many people don’t take their cat ... of a hassle,” but they wouldn’t decide not to take their ... a cavity. The same goes for pets. Just like people want ...
(Date:9/1/2014)... Daily Gossip reveals in it's review on Tattoo ... members access to thousands of professionally designed tattoo images ... to help both people who plan on getting a ... for inspiration in creating one of a kind models. ... visiting the official website at: http://www.dailygossip.org/atattoo-me-now-6444 . , ...
Breaking Medicine News(10 mins):Health News:Train Your Brain to Choose Fruit Salad Over French Fries 2Health News:South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports 2Health News:South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports 3Health News:Permanent AF doubles risk of stroke compared to paroxysmal AF 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 3Health News:Tattoo Me Now Review Reveals Unique Ideas for Tattoo Designs 2
... ongoing decline in the cancer death rate in the ... receive care that addresses the psychological and social problems ... psychological, emotional, and social side effects can increase patients, ... treatment. CANCER CARE FOR THE WHOLE PATIENT: MEETING ...
... October 16, 2007 -- Reducing the number of ... be more cost-effective than most public health and ... at Columbia University Mailman School of Public Health ... that class-size reductions would generate more quality-adjusted life-year ...
... 16 Expected to be,her family,s Halloween treat, Catharine ... pound, 10 ounces. Today, the five-year-old of,Allentown, Pennsylvania has ... who was born 16 weeks early, measuring only 12,inches ... half a million,babies born preterm each year in the ...
... (US Food Sources Preferred Over Imports), FRESNO, Calif., ... surveyed say their confidence in the food supply has,decreased ... conducted by,the California Olive Industry. The registered dieticians ... with 66% saying that when presented with a,choice, they ...
... NASHVILLE, Tenn., Oct. 16 HCA today announced the,appointment ... West Division,which is based in Las Vegas, effective Jan. ... retirement. As Far West Division President, Rogers will ... currently include nine,hospitals and seven ambulatory surgery centers with ...
... The Evening Will Feature Special Performances by John Legend, Joss Stone, ... ... The G&P Foundation for Cancer,Research will honor four outstanding individuals at ... Chief,Executive Officer of BET Networks Debra L. Lee, Chief Hematologic Oncology,Memorial ...
Cached Medicine News:Health News:Study shows reducing class size may be more cost-effective than most medical interventions 2Health News:March of Dimes Selects Pennsylvania Girl as 2008 National Ambassador 2Health News:Dieticians & Nutritionists Report Decreased Confidence in Food Supply 2Health News:Bryan R. Rogers Appointed President of Far West Division 2Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 2Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 3Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 4Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 5
(Date:8/29/2014)... JORDAN, Utah , Aug. 29, 2014  BC ... Solutions, has acquired Polaris Medical Imaging, a leader in ... scanners. This strategic acquisition allows BC Technical to continue ... capabilities, specifically within MR and CT modalities. ... cost service," said Mark Alvarez , president and ...
(Date:8/29/2014)... 2014 Does your doctor know what you,re smoking?  ... recommended marijuana to the over 112,000 currently registered patients under ... of the other roughly 20,300+ active physicians listed with the ... it – even though a poll in February 2014 showed ... have tried it. "With marijuana legalization underway, ...
(Date:8/29/2014)... WASHINGTON , Aug. 29, 2014 Diseases ... a generation ago are returning. Measles was declared ... cases in 2014 as of August 15—the highest incidence ... public health department declared whooping cough a problem ... children are getting sick and dying from these preventable ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
... ALTO, Calif., Dec. 3 Telik, Inc.,(Nasdaq: TELK ... 1,dose-escalation study of TELINTRA(R) (ezatiostat HCl) Tablets at the ... presentation is,scheduled for Saturday, December 8, 2007, from 5:30 ... Georgia World Congress Center in Atlanta. The presentation,(Abstract # ...
... to Phase III Clinical Trial, PALO ALTO, ... Board: AVGO), a late-stage biotechnology company that,develops central ... Phase II data for a combination trial,involving AL-08, ... treatment of ALS. The purpose of the trial ...
Cached Medicine Technology:Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 2Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 3Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 4
... Latex based reagent kit to detect Rheumatoid Factor ... the level of RF semi-quantitatively in the human ... includes antigen coated fine latex particles uniformly suspended ... squeezable dropping bottles, re-usable plastic slide, 50 uL ...
RFScan Latex Test Kit-100...
The Array 360 CEAL streamlines processes with computer enhancements and optimizes productivity by offering an exclusive design for aliquot samples....
ELISA kit for detection of Rheumatoid Factor....
Medicine Products: